SOLICITATION NOTICE
J -- Notice of Intent: FLIPR Tetra, Penta High-Throughput Cellular Screening System (S/N FP1028) Service Plan for the National Center for Translational Sciences (NCATS).
- Notice Date
- 1/7/2022 8:58:37 AM
- Notice Type
- Presolicitation
- NAICS
- 811219
— Other Electronic and Precision Equipment Repair and Maintenance
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 75N95022Q00063
- Response Due
- 1/21/2022 12:00:00 AM
- Point of Contact
- Nick Niefeld, Phone: 3018272094
- E-Mail Address
-
nick.niefeld@nih.gov
(nick.niefeld@nih.gov)
- Description
- PRE-SOLICITATION NOTICE OF INTENT NON-COMPETITIVE SOLICITATION NUMBER 75N95022Q00063 TITLE FLIPR Tetra, Penta High-Throughput Cellular Screening System (S/N FP1028) Service Plan for the National Center for Translational Sciences (NCATS). CLASSIFICATION CODE J066 Maintenance and Repair of Instruments and Laboratory Equipment NAICS CODE 811219 Other Electronic and Precision Equipment Repair and Maintenance RESPONSE DATE January 21, 2022 PRIMARY POINT OF CONTACT Nick Niefeld Contract Specialist nick.niefeld@nih.gov (301) 827-2094 DESCRIPTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). On behalf of the National Center for Advancing Translational Sciences (NCATS), the National Institute on Drug Abuse (NIDA) Office of Acquisition (OA) intends to negotiate on a sole source basis with �Molecular Devices to provide a service agreement for an existing Government-owned Molecular Devices' FLIPR Tetra, Penta High-Throughput Cellular Screening System (S/N FP1028).. NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE and SET ASIDE STATUS The intended procurement is classified under NAICS code 811219 Other Electronic and Precision Equipment Repair and Maintenance with a Size Standard of $22M. This acquisition is NOT set aside for small businesses, but rather is a sole-source acquisition to Molecular Devices. REGULATORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13�Simplified Acquisition Procedures. Contracts awarded using FAR Part 13�Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6�Competition Requirements. FAR Subpart 13.106-1 (b) Soliciting from a single source provides that: For purchases not exceeding the simplified acquisition threshold, Contracting Officers may solicit from one source IF the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name OR industrial mobilization). The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2022-03 dated January 1, 2022. DESCRIPTION OF REQUIREMENT BACKGROUND, PURPOSE AND OBJECTIVES The National Center for Advancing Translational Sciences (NCATS) is a part of the National Institutes of Health (NIH), which mission it is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. The Early Translation Branch (ETB), formerly known as the NCATS Chemical Genomics Center (NCGC), and originally the NIH Chemical Genomics Center, was created in 2008 as a comprehensive screening center in the Molecular Libraries Probe Production Centers Network, part of the NIH Common Fund�s Molecular Libraries Program. The original goals of the ETB were to translate the discoveries of the Human Genome Project into biology and disease insights and ultimately new therapeutics through small molecule assay development, high-throughput screening, informatics, and chemistry. ETB seeks to purchase a warranty for Molecular Devices' FLIPR Tetra high-throughput cellular screening systems (FP1028) and associated robotics to address key technological needs for GPCR, ion channel and stem cell-related projects, all of which have strong implications on the pain and opioid addiction fields of research. ETB's robotic screening system currently features instrumentation to support automated screening of luminescence, fluorescence, and cell-based assays (reagent dispenser, incubators, pintool, and robotic arms), but lacks the capability to perform the extremely time-sensitive dispense/measure flux assays (calcium/potassium flux, membrane potential) that are standard in the GPCR, ion channel and stem cell fields. The maintenance of these FLIPR Tetra instruments makes it possible for ETB to perform state-of-the-art assays in these timely and extremely important scientific domains in a fully automated fashion. ANTICIPATED PERIOD OF PERFORMANCE The anticipated period of performance is one year from date of award. effective at time of award. PLACE OF PERFORMANCE NCATS 9800 Medical Center Dr Building B, Room 201 Rockville, MD 20850 CONTRACT TYPE A firm-fixed price type contract is planned for this acquisition, consistent with commercial practices. CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted. Specifically, Molecular Devices is the only vendor in the marketplace that can provide the products required by the NCATS. Molecular Devices, as the authorized provider of the FLIPR Tetra, Penta High-Throughput Cellular Screening System, is the only contractor authorized and capable of providing the necessary repair and support services on the FLIPR Tetra, Penta High-Throughput Cellular Screening System because the equipment is proprietary. Molecular Devices is the only source for factory trained and certified technicians to provide these services and to maintain and service the equipment. Only Molecular Devices is capable of providing the support services because the equipment is proprietary to this company, the original equipment manufacturer (OEM). Molecular Devices does not authorize any other contractors to perform this work. Use of any other contractor would jeopardize system functionality by risking hardware and software standards. This is turn would jeopardize the NCATS ongoing research studies which would be unacceptable for continuity of science. Accordingly, Molecular Devices is the only contractor capable of meeting the needs of this requirement. Furthermore, use of any other contractor for the system would void equipment warranties and jeopardize system integrity and functionality. Only an OEM-authorized service provider has access to the latest services and support information. Replacement parts or accessories must be compatible with the existing equipment, and only Molecular Devices can certify compatibility. An OEM-authorized service provider is the only source with direct access to these parts and labor. Molecular Devices is the only source authorized by the OEM to provide the parts, supplies, and services for this equipment. Because of the significant investment by NCATS in the purchase of this equipment, using an OEM-Authorized Service Provider is essential for maintaining the integrity of the system. The intended source is: Company Name: Molecular Devices Company Address: 3860 North First St, San Jose, CA 95134 Contact Phone: 1-800-635-5577 DUNS: 125123125 CLOSING STATEMENT This Notice of Intent to Award on a Sole-Source Basis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.�� Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All responses must provide evidence that they can provide the services that meets all of the requirements in this announcement. All responses must be received by the closing date and time of this announcement and must reference the solicitation number, 75N95022Q00063. Responses must be submitted electronically to Nick Niefeld, Contract Specialist, at nick.niefeld@nih.gov. U.S. Mail and fax responses will not be accepted.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/01b859153a274d5c8d22d67c45a34eda/view)
- Place of Performance
- Address: Rockville, MD 20850, USA
- Zip Code: 20850
- Country: USA
- Zip Code: 20850
- Record
- SN06211877-F 20220109/220110105805 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |